- Home
- Funding Opportunities
- Advisory Boards
- President's Cancer Panel
- National Cancer Advisory Board
- Board of Scientific Advisors
- Board of Scientific Counselors
- Clinical Trials and Translational Research Advisory Committee
- NCI Council of Research Advocates
- Frederick National Laboratory Advisory Committee
- NCI Initial Review Groups
- Special Emphasis Panel
- Office of Federal Advisory Committee Policy
- Board Presentations
- Grant Policies
- Consumer Advocates
- NCI
Consumer Guide to Peer Review
The NCI Consumer Guide to Peer Review has been prepared to serve first as an introduction and orientation to the National Cancer Institute (NCI) and its Research Programs and second to define your role as a consumer in the Peer Review of applications that support extramural clinical/population-based research conducted by Cancer Centers, Cooperative Groups, Program Projects, and projects submitted in response to Requests for Applications (RFAs) and Program Announcements (PAs). - Cancer
Dictionary for Peer Review
Cancer Dictionary for Peer Review is deigned to provide concise definitions of technical terms frequently used in applications for NCI-sponsored investigator-initiated research. The terms include those commonly associated with the molecular biology of cancer, immunology, and clinical oncology. These definitions, in association with the review process, will increase your familiarity and understanding of the biology and clinical aspects of cancer. We hope this will facilitate and make your participation in the Peer Review process more meaningful. - Office of Advocacy Relations
- NCI Council of Research Advocates
- NCI
Consumer Guide to Peer Review
- Awarded Research
Grant Policies and Guidelines
NCI and NIH Grant Submission and Review Policies |
---|
Allowable Increase in Requested Direct
Costs of Renewal (Type 2) R01, U01, and P01 Applications
Appeals of
NIH Initial Peer Review; NOT-OD-11-064
Acceptance
for Review of Unsolicited Applications that Request
$500,000 or More in Direct Costs; NOT-OD-02-004
New
and Early Stage Investigator Policies
NIH Policy
on Late Submission of Grant Applications;
NOT-OD-15-039
NIH Policy
Pertaining to Grants to Foreign Institutions,
International Organizations and Domestic Grants with Foreign Components;
NOT-OD-09-010
Resubmissions of NIH Applications
Salary
Limitation on Grants, Cooperative Agreements and Contracts
NCI Select Awards Pay
Policy
NCI Interim C.R. Funding Policy for RPG Awards FY 2025
NCI Interim C.R. Funding Policy for RPG
Awards FY 2025 (PDF version)
Guidance documents
for Fs, Ks, Ts, R15s and S10s
|
Clinical Research/Human Subjects Policies and Guidelines |
---|
Research
Involving Human Subjects
Human Subjects
Policies and Guidance
Human Subjects
Protections Training
Research Using Human
Specimens, Cell Lines, or Data
NIH Policies and NCI
Guidance on Data and Safety Monitoring of
Clinical Trials
NIH Inclusion Policies and
Procedures
Legal
Requirements Regarding the Acquisition and Use of Human Fetal
Tissue for Research Purposes; NIH-OD-15-143
Clinical Trials
Reporting Program
|
NIH Grant Policies |
---|
NIH Grants Policy Statement (Dec 2019)
NIH Financial
Conflict of Interest
Intellectual
Property Policy
NCI/NIH Policies On Sharing Data And
Resources
|